Contact this trialFirst, we need to learn more about you.
Device
AGN1 LOEP for Preventing Secondary Hip Fractures
Recruiting1 award3 criteria
Saint John's, Newfoundland and Labrador
This trial aims to test a new drug, AGN1, to see if it can prevent second hip fractures in women with osteoporosis who are already being treated for their first hip fracture. Around
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service